MtbAIM: AI/ML-guided endpoint-specific prediction of small-molecule activity across drug-susceptible and drug-resistant Mycobacterium tuberculosis
The emergence of drug resistance creates a critical gap in antitubercular lead prioritization, as small-molecules identified against drug-susceptible (DS)